TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
217,626
|
255,981
|
210,828 |
| Financial expenses |
4,468
|
2,551
|
1,424 |
| Earnings before taxes |
19,223
|
49,144
|
45,134 |
| EBITDA |
22,802
|
55,633
|
51,230 |
| Total assets |
128,065
|
133,944
|
132,839 |
| Current assets |
120,227
|
123,855
|
118,148 |
| Current liabilities |
23,629
|
38,625
|
56,813 |
| Equity capital |
61,040
|
50,837
|
24,638 |
| - share capital |
130
|
134
|
134 |
| Employees (average) |
31
|
27
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.7%
|
38.0%
|
18.5% |
| Turnover per employee |
7,020
|
9,481
|
7,808 |
| Profit as a percentage of turnover |
8.8%
|
19.2%
|
21.4% |
| Return on assets (ROA) |
18.5%
|
38.6%
|
35.0% |
| Current ratio |
508.8%
|
320.7%
|
208.0% |
| Return on equity (ROE) |
31.5%
|
96.7%
|
183.2% |
| Change turnover |
-29,889
|
44,067
|
44,941 |
| Change turnover % |
-12%
|
21%
|
27% |
| Chg. No. of employees |
4
|
0
|
2 |
| Chg. No. of employees % |
15%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.